BioPharma Dive February 20, 2025
A Missouri district court judge on Tuesday said stopping the FTC’s suit against the three largest PBMs would be “against the public’s interest.”
Dive Brief:
- The Federal Trade Commission’s lawsuit against major pharmacy benefit managers can move forward after a judge declined to halt the case.
- In September, the FTC sued Caremark, Express Scripts and Optum Rx over business practices that regulators said were artificially driving up the cost of insulin. The three PBMs, which are respectively owned by CVS, Cigna and UnitedHealth, asked a Missouri district court two months later to block the agency’s suit, calling it unconstitutional.
- On Tuesday, the judge rejected the PBMs’ request as lacking sufficient merit.
Dive Insight:
The FTC’s lawsuit against Caremark,...